Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

309.82
Delayed Data
As of 3:59pm ET
 -2.76 / -0.88%
Today’s Change
223.02
Today|||52-Week Range
333.65
+1.13%
Year-to-Date

Today’s Trading

Previous close312.58
Today’s open311.67
Day’s range308.68 - 312.02
Volume924,232
Average volume (3 months)1,895,860
Market cap$68.5B
Dividend yield--
Data as of 3:59pm ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)+24.01%
Earnings growth (this year)+16.59%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)-3.87%
P/E ratio18.1
Price/Sales7.60
Price/Book7.29

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.75-0.92%
ILMNIllumina Inc-0.86-0.48%
AMGNAmgen-1.27-0.73%
NBIXNeurocrine Bioscienc...-0.69-1.28%
Data as of 4:14pm ET, 09/26/2016

Financials

Next reporting dateOctober 26, 2016
EPS forecast (this quarter)$5.02
Annual revenue (last year)$9.3B
Annual profit (last year)$3.5B
Net profit margin38.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
George A. Scangos
Chief Scientific Officer &
Executive VP
Spyridon Artavanis-Tsakonas
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Search for Jobs